Related Experiment Video
Updated: Jun 29, 2025
10:03
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
5.3K
S100A8/A9 as a prognostic biomarker with causal effects for post-acute myocardial infarction heart failure
Jie Ma1,2, Yang Li1,2, Ping Li1
1Beijing Anzhen Hospital of Capital Medical University, Beijing, China.
Nature Communications
|March 28, 2024
Summary
Elevated S100A8/A9 protein levels predict heart failure after acute myocardial infarction. This biomarker offers superior prediction compared to traditional markers and shows a potential causal link.
Area of Science:
- Cardiology
- Biomarker Discovery
- Proteomics
Background:
- Heart failure is a common complication following acute myocardial infarction.
- Identifying reliable biomarkers for post-myocardial infarction heart failure is crucial for patient management.
Purpose of the Study:
- To identify and validate a novel biomarker for predicting heart failure after acute myocardial infarction.
- To assess the predictive performance of the identified biomarker against traditional risk factors.
Main Methods:
- Proteomic analysis was used to screen potential biomarkers in discovery and validation cohorts (1062 and 1043 patients, respectively).
- Observational study design to evaluate associations with in-hospital and long-term heart failure events.
- Mendelian randomization was employed to investigate the causal effect of the biomarker on heart failure.
Main Results:
- Elevated circulating S100A8/A9 levels were independently associated with heart failure in both discovery and validation cohorts.
- S100A8/A9 demonstrated superior predictive value compared to traditional biomarkers.
- Incorporating S100A8/A9 improved risk estimation when added to traditional risk factors.
Conclusions:
- S100A8/A9 is a significant predictor of heart failure post-acute myocardial infarction.
- S100A8/A9 may act as a causal mediator in the development of heart failure.
- This biomarker holds potential for enhanced risk stratification and management of patients post-myocardial infarction.
More Related Videos
Related Concept Videos
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
144
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
144
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
81
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
81